Norditropin Flexpro (Somatropin)

Somatropin, the active ingredient in Norditropin Flexpro, is a human growth hormone presented as a sterile solution for subcutaneous use. It is prescribed to treat growth hormone deficiency and related growth disorders in children, adolescents, and adults, and to support normal growth and metabolic functions in specific genetic or renal conditions.

GNH USA supplies Norditropin Flexpro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product meets EU regulatory standards and is manufactured under GMP conditions, ensuring consistent potency and safety for patients.

Norditropin Flexpro, a recombinant human growth hormone, is used in several endocrine and genetic conditions that affect growth.

- Growth hormone deficiency in children and adolescents: promotes linear growth and improves height velocity. - Turner syndrome: enhances growth potential and increases final adult stature. - Prader‑Willi syndrome: supports growth and improves body composition. - Chronic renal insufficiency: helps counteract growth retardation associated with renal disease. - Adult growth hormone deficiency: restores metabolic balance and improves quality of life.

Somatropin may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Injection site pain or erythema - Headache - Transient edema, especially in the extremities - Joint stiffness or arthralgia

Serious or Rare Side Effects: - Intracranial hypertension - Development of anti‑GH antibodies leading to reduced efficacy - Hyperglycemia or new‑onset diabetes mellitus

When prescribing Somatropin, clinicians should consider several safety precautions to minimize risks.

- Assess for active malignancy: avoid use in patients with known cancer due to potential growth stimulation. - Monitor glucose metabolism: check fasting glucose and HbA1c regularly in at‑risk individuals. - Evaluate intracranial pressure: watch for signs of headache, visual changes, or nausea. - Screen for thyroid function: hypothyroidism can worsen during therapy and should be corrected. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Somatropin can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Glucocorticoids: high‑dose steroids may blunt the growth‑promoting effects of somatropin. - Antidiabetic agents: somatropin can exacerbate hyperglycemia, requiring dose adjustment of insulin or oral hypoglycemics.

Moderate Interactions (Monitor Closely): - Thyroid hormone replacement: adequate levothyroxine is needed to achieve full growth response. - Estrogen therapy: high estrogen levels can reduce somatropin effectiveness in adolescents. - Oral contraceptives: may slightly increase IGF‑1 levels, necessitating monitoring.